A Descriptive Study on The Safety and Efficacy of Mesenchymal Stem Cell Therapy For Parkinson’s Disease: A Case Series Post author:2by2host Post published:September 11, 2017 Post category:Articles / Stem Cells Please Share This Share this content Opens in a new window X Opens in a new window Facebook Opens in a new window Pinterest Opens in a new window LinkedIn Opens in a new window Viber Opens in a new window VK Opens in a new window Reddit Opens in a new window Tumblr Opens in a new window Viadeo Opens in a new window WhatsApp You Might Also Like Neuroglial Activation and Neuroinflammation in the Brain of Patients with Autism May 12, 2008 Clinical Outcomes of Transplanted Modified Bone Marrow–Derived Mesenchymal Stem Cells in Stroke: A Phase 1/2a Study September 25, 2017 Short-Term Effect of Autologous Bone Marrow Stem Cells to Treat Acute Myocardial Infarction: A Meta-Analysis of Randomized Controlled Clinical Trials March 10, 2017
Clinical Outcomes of Transplanted Modified Bone Marrow–Derived Mesenchymal Stem Cells in Stroke: A Phase 1/2a Study September 25, 2017
Short-Term Effect of Autologous Bone Marrow Stem Cells to Treat Acute Myocardial Infarction: A Meta-Analysis of Randomized Controlled Clinical Trials March 10, 2017